MEDCOLCANNA ANNOUNCES CHANGE TO VIRTUAL ANNUAL GENERAL MEETING ON MAY 21, 2020
BOGOTÁ, Colombia – May 19, 2020 – Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna”, “MCCN” or the “Company”), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Thursday, May 21, 2020 at 11:00 a.m. (Bogota time) at the offices of the […]
BOGOTÁ, Colombia – May 19, 2020 – Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna”, “MCCN” or the “Company”), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Thursday, May 21, 2020 at 11:00 a.m. (Bogota time) at the offices of the Company will be changed to a virtual meeting to be held at the same time and on the same date.
As Colombia has declared a state of public health emergency, and to support efforts to combat the spread of COVID-19, Medcolcanna has made the decision to change its in person annual general and special meeting to a virtual format. We believe hosting a virtual meeting in the face of the COVID-19 pandemic is in the best interests of all stakeholders and the broader community. Shareholders will not be able to attend the annual general and special meeting in person.
The virtual meeting will be conducted via live audio and video webcast using Zoom using the following information: Meeting ID: 244 663 0137, Password: 439537 commencing at 11:00 a.m. (Bogota time) on May 21, 2020. Shareholders will have an opportunity to participate at the annual general and special meeting online regardless of their geographic location.
Registered shareholders and duly appointed proxyholders will be able to listen to the virtual meeting and ask questions, all in real time, provided they are signed in to Zoom and indicate that they wish to ask a question.
Non-registered (beneficial) shareholders who have not duly appointed themselves as proxyholders may still attend the virtual meeting as guests. Guests will be able to listen to the meeting but will not be able to vote at the meeting.
We recommend that you log in to the webcast at least fifteen minutes before the time of the virtual meeting and if you encounter any technical difficulties, please contact the Corporate Secretary of the Company, Peter Yates, at (403) 971-9104 or by e-mail at email@example.com.
Medcolcannna encourages all shareholders to participate in the virtual annual general and special meeting. If you are unable to attend the virtual meeting, we encourage you to complete the form of proxy or voting instruction form previously mailed to you and return it within the time frames indicated on such forms so that your vote is counted at the virtual meeting.
Please note that in light of the rapidly evolving environment related to the COVID-19 outbreak, the ability to hold the virtual meeting as planned could be compromised. Should the Company be required to alter its plans regarding the virtual meeting, leading to a cancellation or postponement, the details of any such change would be communicated via press release and made available on the Company’s profile at www.sedar.com.
Medcolcanna is a Canadian integrated medical cannabis company, whose fully licensed operations are based in Colombia. Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which positions the Company to become a global leader in the medical cannabis market.
Medcolcanna employs state of the art organic agricultural technology and innovative pharmaceutical processes to produce high-quality products. The Company’s scalable production model and network of pharmaceutical partnerships globally ensures that they remain at the forefront of the medical cannabis industry.
Additional information about Medcolcanna can be found on its web site at www.medcolcanna.com
Neither the TSX Venture Exchange Inc. nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Investor Relations Contact:
Chris Reid, CFO
Carrera 49b # 93-62
Felipe de la Vega, CEO
Carrera 49b # 93-62